Heterogeneity of tumor endothelial cells: Comparison between tumor endothelial cells isolated from high- and low-metastatic tumors

American Journal of Pathology

Volumn 180, Issue 3, 2012, Pages 1294-1307

  Ohga, Noritaka ^a   Ishikawa, Shuhei ^a,b   Maishi, Nako ^a   Akiyama, Kosuke ^a   Hida, Yasuhiro ^b   Kawamoto, Taisuke ^a   Sadamoto, Yoshihiro ^a   Osawa, Takahiro ^a,b   Yamamoto, Kazuyuki ^a,b   Kondoh, Miyako ^a   Ohmura, Hitomi ^a   Shinohara, Nobuo ^b   Nonomura, Katsuya ^b   Shindoh, Masanobu ^a   Hida, Kyoko ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; FLUOROURACIL; GLYCOPROTEIN P; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; PACLITAXEL; THY 1 ANTIGEN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANEUPLOIDY; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RESISTANCE; CANCER STEM CELL; CELL DIFFERENTIATION; CELL HETEROGENEITY; CELL INVASION; CELL ISOLATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG SENSITIVITY; ENDOTHELIUM CELL; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOXEMIA; MELANOMA; METASTASIS; MOUSE; NONHUMAN; OSTEOBLAST; PERICYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPHEROID CELL; TUMOR BLOOD VESSEL; TUMOR CELL; TUMOR ENDOTHELIAL CELL; TUMOR VASCULARIZATION; UPREGULATION;

ANEUPLOIDY; ANIMALS; CELL HYPOXIA; DRUG RESISTANCE, NEOPLASM; ENDOTHELIAL CELLS; FEMALE; HUMANS; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC; P-GLYCOPROTEIN; PERICYTES; PHENOTYPE; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 84863393758     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.11.035     Document Type: Article

References (52)

1. J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease Nat Med 1 1995 27 31
2. K. Hida, Y. Hida, M. Shindoh Understanding tumor endothelial cell abnormalities to develop ideal anti-angiogenic therapies Cancer Sci 99 2008 459 466
3. J. Folkman Role of angiogenesis in tumor growth and metastasis Semin Oncol 29 2002 15 18
4. I.J. Fidler Angiogenic heterogeneity: regulation of neoplastic angiogenesis by the organ microenvironment J Natl Cancer Inst 93 2001 1040 1041
5. D.M. McDonald, P.L. Choyke Imaging of angiogenesis: from microscope to clinic Nat Med 9 2003 713 725
6. S. Morikawa, P. Baluk, T. Kaidoh, A. Haskell, R.K. Jain, D.M. McDonald Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors Am J Pathol 160 2002 985 1000
7. T. Akino, K. Hida, Y. Hida, K. Tsuchiya, D. Freedman, C. Muraki, N. Ohga, K. Matsuda, K. Akiyama, T. Harabayashi, N. Shinohara, K. Nonomura, M. Klagsbrun, M. Shindoh Cytogenetic abnormalities of tumor-associated endothelial cells in human malignant tumors Am J Pathol 175 2009 2657 2667
8. D.N. Amin, K. Hida, D.R. Bielenberg, M. Klagsbrun Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors Cancer Res 66 2006 2173 2180
9. K. Hida, Y. Hida, D.N. Amin, A.F. Flint, D. Panigrahy, C.C. Morton, M. Klagsbrun Tumor-associated endothelial cells with cytogenetic abnormalities Cancer Res 64 2004 8249 8255
10. T. Kurosu, N. Ohga, Y. Hida, N. Maishi, K. Akiyama, W. Kakuguchi, T. Kuroshima, M. Kondo, T. Akino, Y. Totsuka, M. Shindoh, F. Higashino, K. Hida HuR keeps an angiogenic switch on by stabilising mRNA of VEGF and COX-2 in tumour endothelium Br J Cancer 104 2011 819 829
11. K. Matsuda, N. Ohga, Y. Hida, C. Muraki, K. Tsuchiya, T. Kurosu, T. Akino, S.C. Shih, Y. Totsuka, M. Klagsbrun, M. Shindoh, K. Hida Isolated tumor endothelial cells maintain specific character during long-term culture Biochem Biophys Res Commun 394 2010 947 954
12. N. Ohga, K. Hida, Y. Hida, C. Muraki, K. Tsuchiya, K. Matsuda, Y. Ohiro, Y. Totsuka, M. Shindoh Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and endothelial progenitor cells Cancer Sci 100 2009 1963 1970
13. K. Tsuchiya, K. Hida, Y. Hida, C. Muraki, N. Ohga, T. Akino, T. Kondo, T. Miseki, K. Nakagawa, M. Shindoh, T. Harabayashi, N. Shinohara, K. Nonomura, M. Kobayashi Adrenomedullin antagonist suppresses tumor formation in renal cell carcinoma through inhibitory effects on tumor endothelial cells and endothelial progenitor mobilization Int J Oncol 36 2010 1379 1386
14. W.C. Aird Mechanisms of endothelial cell heterogeneity in health and disease Circ Res 98 2006 159 162
15. W.C. Aird Molecular heterogeneity of tumor endothelium Cell Tissue Res 335 2009 271 281
16. J.M. Kozlowski, I.R. Hart, I.J. Fidler, N. Hanna A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice J Natl Cancer Inst 72 1984 913 917
17. A. Tsuchiya, T. Heike, S. Baba, H. Fujino, K. Umeda, Y. Matsuda, M. Nomoto, T. Ichida, Y. Aoyagi, T. Nakahata Sca-1+ endothelial cells (SPECs) reside in the portal area of the liver and contribute to rapid recovery from acute liver disease Biochem Biophys Res Commun 365 2008 595 601
18. D.R. Bielenberg, Y. Hida, A. Shimizu, A. Kaipainen, M. Kreuter, C.C. Kim, M. Klagsbrun Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype J Clin Invest 114 2004 1260 1271
19. J. Hamada, P.G. Cavanaugh, K. Miki, G.L. Nicolson A paracrine migration-stimulating factor for metastatic tumor cells secreted by mouse hepatic sinusoidal endothelial cells: identification as complement component C3b Cancer Res 53 1993 4418 4423
20. J.L. Arbiser, G. Raab, R.M. Rohan, S. Paul, K. Hirschi, E. Flynn, E.R. Price, D.E. Fisher, C. Cohen, M. Klagsbrun Isolation of mouse stromal cells associated with a human tumor using differential diphtheria toxin sensitivity Am J Pathol 155 1999 723 729
21. B. Bussolati, B. Assenzio, M.C. Deregibus, G. Camussi The proangiogenic phenotype of human tumor-derived endothelial cells depends on thrombospondin-1 downregulation via phosphatidylinositol 3-kinase/Akt pathway J Mol Med 84 2006 852 863
22. K.H. Plate, G. Breier, H.A. Weich, W. Risau Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo Nature 359 1992 845 848
23. P. Carmeliet, Y. Dor, J.M. Herbert, D. Fukumura, K. Brusselmans, M. Dewerchin, M. Neeman, F. Bono, R. Abramovitch, P. Maxwell, C.J. Koch, P. Ratcliffe, L. Moons, R.K. Jain, D. Collen, E. Keshert Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis Nature 394 1998 485 490
24. D. Kim, S. Kim, H. Koh, S.O. Yoon, A.S. Chung, K.S. Cho, J. Chung Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production FASEB J 15 2001 1953 1962
25. C. Grange, B. Bussolati, S. Bruno, V. Fonsato, A. Sapino, G. Camussi Isolation and characterization of human breast tumor-derived endothelial cells Oncol Rep 15 2006 381 386
26. A.C. Dudley, M. Klagsbrun Tumor endothelial cells join the resistance Clin Cancer Res 15 2009 4787 4789
27. T. Tsuruo, M. Naito, A. Tomida, N. Fujita, T. Mashima, H. Sakamoto, N. Haga Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal Cancer Sci 94 2003 15 21
28. C. Holmes, W.L. Stanford Concise review: stem cell antigen-1: expression, function, and enigma Stem Cells 25 2007 1339 1347
29. A.C. Dudley, Z.A. Khan, S.C. Shih, S.Y. Kang, B.M. Zwaans, J. Bischoff, M. Klagsbrun Calcification of multipotent prostate tumor endothelium Cancer Cell 14 2008 201 211
30. R. Li, R. Hehlman, R. Sachs, P. Duesberg Chromosomal alterations cause the high rates and wide ranges of drug resistance in cancer cells Cancer Genet Cytogenet 163 2005 44 56
31. P. Duesberg, D. Rasnick, R. Li, L. Winters, C. Rausch, R. Hehlmann How aneuploidy may cause cancer and genetic instability Anticancer Res 19 1999 4887 4906
32. D.G. Duda, K.S. Cohen, S.V. Kozin, J.Y. Perentes, D. Fukumura, D.T. Scadden, R.K. Jain Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors Blood 107 2006 2774 2776
33. N. Takakura Role of hematopoietic lineage cells as accessory components in blood vessel formation Cancer Sci 97 2006 568 574
34. S. Bruno, B. Bussolati, C. Grange, F. Collino, M.E. Graziano, U. Ferrando, G. Camussi CD133+ renal progenitor cells contribute to tumor angiogenesis Am J Pathol 169 2006 2223 2235
35. B. Bussolati, M.C. Deregibus, G. Camussi Characterization of molecular and functional alterations of tumor endothelial cells to design anti-angiogenic strategies Curr Vasc Pharmacol 8 2010 220 232
36. D. Gao, V. Mittal The role of bone-marrow-derived cells in tumor growth, metastasis initiation and progression Trends Mol Med 15 2009 333 343
37. D. Gao, D. Nolan, K. McDonnell, L. Vahdat, R. Benezra, N. Altorki, V. Mittal Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression Biochim Biophys Acta 1796 2009 33 40
38. E. Langenkamp, G. Molema Microvascular endothelial cell heterogeneity: general concepts and pharmacological consequences for anti-angiogenic therapy of cancer Cell Tissue Res 335 2009 205 222
39. G. Molema Heterogeneity in endothelial responsiveness to cytokines, molecular causes, and pharmacological consequences Semin Thromb Hemost 36 2010 246 264
40. D. Shweiki, A. Itin, D. Soffer, E. Keshet Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis Nature 359 1992 843 845
41. H.P. Gerber, A. McMurtrey, J. Kowalski, M. Yan, B.A. Keyt, V. Dixit, N. Ferrara Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway: requirement for Flk-1/KDR activation J Biol Chem 273 1998 30336 30343
42. G. Fassina, R. Vene, M. Morini, S. Minghelli, R. Benelli, D.M. Noonan, A. Albini Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate Clin Cancer Res 10 2004 4865 4873
43. R. Adya, B.K. Tan, A. Punn, J. Chen, H.S. Randeva Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis Cardiovasc Res 78 2008 356 365
44. D.J. Nolan, A. Ciarrocchi, A.S. Mellick, J.S. Jaggi, K. Bambino, S. Gupta, E. Heikamp, M.R. McDevitt, D.A. Scheinberg, R. Benezra, V. Mittal Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization Genes Dev 21 2007 1546 1558
45. A.E. Karnoub, A.B. Dash, A.P. Vo, A. Sullivan, M.W. Brooks, G.W. Bell, A.L. Richardson, K. Polyak, R. Tubo, R.A. Weinberg Mesenchymal stem cells within tumor stroma promote breast cancer metastasis Nature 449 2007 557 563
46. J.F. de Groot, G. Fuller, A.J. Kumar, Y. Piao, K. Eterovic, Y. Ji, C.A. Conrad Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice Neuro Oncol 12 2010 233 242
47. Y. Sato Persistent vascular normalization as an alternative goal of anti-angiogenic cancer therapy Cancer Sci 102 2011 1253 1256
48. I. Helfrich, I. Scheffrahn, S. Bartling, J. Weis, V. von Felbert, M. Middleton, M. Kato, S. Ergun, D. Schadendorf Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma J Exp Med 207 2010 491 503
49. S.M. Taylor, K.R. Nevis, H.L. Park, G.C. Rogers, S.L. Rogers, J.G. Cook, V.L. Bautch Angiogenic factor signaling regulates centrosome duplication in endothelial cells of developing blood vessels Blood 116 2010 3108 3117
50. B. Sarkadi, L. Homolya, G. Szakacs, A. Varadi Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system Physiol Rev 86 2006 1179 1236
51. M. Paez-Ribes, E. Allen, J. Hudock, T. Takeda, H. Okuyama, F. Vinals, M. Inoue, G. Bergers, D. Hanahan, O. Casanovas Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis Cancer Cell 15 2009 220 231
52. J.M. Ebos, C.R. Lee, W. Cruz-Munoz, G.A. Bjarnason, J.G. Christensen, R.S. Kerbel Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis Cancer Cell 15 2009 232 239